Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2022 Mar 15;10(1):E183-E189.
doi: 10.9778/cmajo.20200249. Print 2022 Jan-Mar.

Neighbourhood-level material deprivation and response to combination antiretroviral therapy in the Canadian Observational Cohort (CANOC): a longitudinal cohort study

Alison R McClean  1 , Jason Trigg  2 , Monica Ye  2 , Taylor McLinden  2 , Katherine W Kooij  2 , Nicanor Bacani  2 , Christian Hui  2 , Paul Sereda  2 , Ann N Burchell  2 , Sharon L Walmsley  2 , Deborah Kelly  2 , Nimâ Machouf  2 , Julio S G Montaner  2 , Mona Loutfy  2 , Robert S Hogg  2 ; CANOC Collaboration
Affiliations
Observational Study

Neighbourhood-level material deprivation and response to combination antiretroviral therapy in the Canadian Observational Cohort (CANOC): a longitudinal cohort study

Alison R McClean et al. CMAJ Open. .

Abstract

Background: Socioeconomic status has been associated with higher viral loads and lower CD4 cell counts among people living with HIV. The objective of this study was to evaluate the relation between neighbourhood-level material deprivation and immunologic and virologic response to combination antiretroviral therapy (ART) among people living with HIV in Canada.

Methods: The Canadian Observational Cohort (CANOC) is a longitudinal cohort of people living with HIV, containing data from 2000-2016 from 5 Canadian provinces. We defined response to combination ART as positive if the CD4 cell count increased by 50 cells/mm3 (0.05 cells × 109/L) or more (CD4+) and viral load decreased to 50 copies/mL or less (VL+) within 6 months of treatment initiation. We further categorized response to therapy as concordant positive (CD4+/VL+), concordant negative (CD4-/VL-) or discordant (CD4+/VL- or CD4-/VL+). We used adjusted multinomial logistic regression to quantify the relation between neighbourhood-level material deprivation and immunologic and virologic response.

Results: This study included 8274 people living with HIV, of which 1754 (21.2%) lived in the most materially deprived neighbourhoods. Most individuals (62.2%) showed a concordant positive response to combination ART. After adjustment, living in the most materially deprived neighbourhoods was associated with a CD4-/VL+ discordant response (adjusted odds ratio [OR] 1.31, 95% confidence interval [CI] 1.06-1.62) and a concordant negative response (adjusted OR 1.45, 95% CI 1.13-1.86), using a concordant positive response as the reference. No other deprivation quartile was independently associated with a particular response.

Interpretation: People living with HIV from the most materially deprived neighbourhoods had increased odds of poor immunologic or virologic response to combination ART. These results motivate further study of the specific socioeconomic factors that potentially affect response to combination ART among people living with HIV in Canada.

PubMed Disclaimer

Conflict of interest statement

Competing interests: Sharon Walmsley has served on advisory boards, received consulting fees, attended speaking engagements, meetings and symposia, and conducted clinical studies for ViiV Healthcare, GlaxoSmithKline, Gilead and Merck. Deborah Kelly has served on advisory boards and has received consulting fees from Gilead Sciences and Viiv Healthcare. Nimâ Machouf reports speaking fees from Gilead. Julio Montaner has received institutional support from the BC Ministry of Health and the Public Health Agency of Canada, as well as Gilead, Merck and Viiv Healthcare. Mona Loutfy has received grants from ViiV Healthcare, Merck, AbbVie and Gilead. All competing interests are outside this work. No other competing interests were declared.

References

    1. Montaner JS, Lima V, Harrigan P, et al. Expansion of HAART coverage is associated with sustained decreases in HIV/AIDS morbidity, mortality and HIV transmission: the “HIV treatment as prevention” experience in a Canadian setting. PLoS One. 2014;9:e87872. - PMC - PubMed
    1. Moore DM, Hogg R, Yip B, et al. Discordant immunologic and virologic responses to highly active antiretroviral therapy are associated with increased mortality and poor adherence to therapy. J Acquir Immune Defic Syndr. 2005;40:288–93. - PubMed
    1. Tan R, Westfall A, Willig J, et al. Clinical outcomes of HIV-infected antiretroviral-naive patients with discordant immunologic and virologic responses to highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2008;47:553–8. - PubMed
    1. Grabar S, Moing V, Goujard C, et al. Clinical outcome of patients with HIV-1 infection according to immunologic and virologic response after 6 months of highly active antiretroviral therapy. Ann Intern Med. 2000;133:401–10. - PubMed
    1. Kelly C, Gaskell K, Richardson M, et al. Discordant immune response with antiretroviral therapy in HIV-1: a systematic review of clinical outcomes. PLoS One. 2016;11:e0156099. - PMC - PubMed

Publication types